122 related articles for article (PubMed ID: 31408784)
1. Puerarin protects pulmonary arteries from hypoxic injury through the BMPRII and PPARγ signaling pathways in endothelial cells.
Yuan T; Zhang H; Chen D; Chen Y; Lyu Y; Fang L; Du G
Pharmacol Rep; 2019 Oct; 71(5):855-861. PubMed ID: 31408784
[TBL] [Abstract][Full Text] [Related]
2. FGF21 attenuates hypoxia‑induced dysfunction and apoptosis in HPAECs through alleviating endoplasmic reticulum stress.
Chen A; Liu J; Zhu J; Wang X; Xu Z; Cui Z; Yao D; Huang Z; Xu M; Chen M; Wu P; Li M; Wang L; Huang X
Int J Mol Med; 2018 Sep; 42(3):1684-1694. PubMed ID: 29845288
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin protects human pulmonary artery endothelial cells against hypoxia-induced injury via PI3-kinase/Akt.
Yang D; Liu Z; Zhang H; Luo Q
Peptides; 2013 Apr; 42():112-7. PubMed ID: 23391508
[TBL] [Abstract][Full Text] [Related]
4. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
Hennigs JK; Cao A; Li CG; Shi M; Mienert J; Miyagawa K; Körbelin J; Marciano DP; Chen PI; Roughley M; Elliott MV; Harper RL; Bill MA; Chappell J; Moonen JR; Diebold I; Wang L; Snyder MP; Rabinovitch M
Circ Res; 2021 Feb; 128(3):401-418. PubMed ID: 33322916
[TBL] [Abstract][Full Text] [Related]
5. Puerarin induces mitochondria-dependent apoptosis in hypoxic human pulmonary arterial smooth muscle cells.
Chen C; Chen C; Wang Z; Wang L; Yang L; Ding M; Ding C; Sun Y; Lin Q; Huang X; Du X; Zhao X; Wang C
PLoS One; 2012; 7(3):e34181. PubMed ID: 22457823
[TBL] [Abstract][Full Text] [Related]
6. Nicorandil inhibits hypoxia-induced apoptosis in human pulmonary artery endothelial cells through activation of mitoKATP and regulation of eNOS and the NF-κB pathway.
Wang H; Zuo X; Wang Q; Yu Y; Xie L; Wang H; Wu H; Xie W
Int J Mol Med; 2013 Jul; 32(1):187-94. PubMed ID: 23670355
[TBL] [Abstract][Full Text] [Related]
7. ITE promotes hypoxia-induced transdifferentiation of human pulmonary arterial endothelial cells possibly by activating transforming growth factor-β/Smads and MAPK/ERK pathways.
Wang J; Yan G; Guo H; Zhu Y; Shui X; He Y; Chen C; Lei W
J Cell Biochem; 2019 Dec; 120(12):19567-19577. PubMed ID: 31297875
[TBL] [Abstract][Full Text] [Related]
8. Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways.
Zhang H; Liu Y; Lao M; Ma Z; Yi X
Exp Gerontol; 2011 Jan; 46(1):30-7. PubMed ID: 20933077
[TBL] [Abstract][Full Text] [Related]
9. β-arrestin1 inhibits hypoxic injury-induced autophagy in human pulmonary artery endothelial cells via the Akt/mTOR signaling pathway.
Ning H; Deng J; Chen F; Liu Y; Kong D; Shan L; Zhang Z; Hu T
Int J Biochem Cell Biol; 2020 Aug; 125():105791. PubMed ID: 32544529
[TBL] [Abstract][Full Text] [Related]
10. Emodin, A Chinese Herbal Medicine, Inhibits Reoxygenation-Induced Injury in Cultured Human Aortic Endothelial Cells by Regulating the Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) and Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathway.
Shou X; Zhou R; Zhu L; Ren A; Wang L; Wang Y; Zhou J; Liu X; Wang B
Med Sci Monit; 2018 Feb; 24():643-651. PubMed ID: 29386501
[TBL] [Abstract][Full Text] [Related]
11. Puerarin prevents progression of experimental hypoxia-induced pulmonary hypertension via inhibition of autophagy.
Zhang X; Liu Q; Zhang C; Sheng J; Li S; Li W; Yang X; Wang X; He S; Bai J; Zhu D
J Pharmacol Sci; 2019 Oct; 141(2):97-105. PubMed ID: 31640920
[TBL] [Abstract][Full Text] [Related]
12. FGF21 attenuates hypoxia‑induced dysfunction and inflammation in HPAECs via the microRNA‑27b‑mediated PPARγ pathway.
Yao D; He Q; Sun J; Cai L; Wei J; Cai G; Liu J; Lin Y; Wang L; Huang X
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907846
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling.
Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770
[TBL] [Abstract][Full Text] [Related]
14. Formononetin protects against ox-LDL-induced endothelial dysfunction by activating PPAR-γ signaling based on network pharmacology and experimental validation.
Zhang B; Hao Z; Zhou W; Zhang S; Sun M; Li H; Hou N; Jing C; Zhao M
Bioengineered; 2021 Dec; 12(1):4887-4898. PubMed ID: 34369277
[TBL] [Abstract][Full Text] [Related]
15. Puerarin attenuates the endothelial-mesenchymal transition induced by oxidative stress in human coronary artery endothelial cells through PI3K/AKT pathway.
Li X; Sun S; Chen D; Yuan T; Chen Y; Wang D; Fang L; Lu Y; Du G
Eur J Pharmacol; 2020 Nov; 886():173472. PubMed ID: 32860809
[TBL] [Abstract][Full Text] [Related]
16. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase.
Hwang YP; Kim HG; Hien TT; Jeong MH; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2011 Nov; 257(1):48-58. PubMed ID: 21884717
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature.
Kang BY; Park KK; Green DE; Bijli KM; Searles CD; Sutliff RL; Hart CM
PLoS One; 2013; 8(11):e79503. PubMed ID: 24244514
[TBL] [Abstract][Full Text] [Related]
18. Anti-hypoxic effect of dihydroartemisinin on pulmonary artery endothelial cells.
Yu H; Liu J; Dong Y; Xu M; Xu L; Guan H; Xia X; Wang L
Biochem Biophys Res Commun; 2018 Dec; 506(4):840-846. PubMed ID: 30391003
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
[TBL] [Abstract][Full Text] [Related]
20. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS.
Bao MH; Zhang YW; Lou XY; Xiao Y; Cheng Y; Zhou HH
Can J Physiol Pharmacol; 2014 Apr; 92(4):299-306. PubMed ID: 24708212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
